Articles Related to Preeclampsia
Labetalol in Comparison to Methyl Dopa in Treatment of Gestational Hypertension, A Randomized Trial
To evaluate the value and safety of labetalol in comparison to Alfa methyldopa in treatment of pregnant women with pregnancy-induced hypertension (PIH). 264 patients with PIH were randomly distributed to take either methyldopa (group 1) labetalol (group 2). or Intake of medications with respect to Age, gravidity, Blood Pressure measurement, albumin in urine measurement Levels, Side Effects, dose of the drug, increasing duration of pregnancy, mode of delivery, Perinatal safety and APGAR scores were studied. The statistical level of significance was taken at P<0.05.
Case Report of Severe Preeclampsia and Associated Postpartum Complications
Preeclampsia is clinically defined by hypertension and proteinuria, with or without pathologic edema that occurs after 20 weeks’ gestation, but can also present up to 4-6 weeks post-partum. Worldwide, incidence of preeclampsia is 5-14 percent of all pregnancies, while severe preeclampsia can develop to about 25 percent of all cases of preeclampsia.
Editorial Board Members Related to Preeclampsia
WANG CHI CHIU
Professor
Department of Obstetrics & Gynecology
The Chinese University of Hong Kong
Hong Kong
Department of Obstetrics & Gynecology
The Chinese University of Hong Kong
Hong Kong